USD 28.5
(-1.96%)
Year | Total Liabilities | Total Liabilities Growth |
---|---|---|
2024 | 119.63 Million USD | 44.55% |
2023 | 82.23 Million USD | 6.53% |
2022 | 77.19 Million USD | 21.84% |
2021 | 63.36 Million USD | 11.37% |
2020 | 56.89 Million USD | -78.95% |
2019 | 270.23 Million USD | 20.2% |
2018 | 224.81 Million USD | 0.0% |
Year | Total Liabilities | Total Liabilities Growth |
---|---|---|
2024 Q4 | 119.63 Million USD | 8.71% |
2024 FY | 119.63 Million USD | 45.48% |
2024 Q1 | 90.24 Million USD | 9.73% |
2024 Q2 | 93.42 Million USD | 3.53% |
2024 Q3 | 110.04 Million USD | 17.8% |
2023 Q1 | 77.87 Million USD | 0.88% |
2023 Q4 | 82.23 Million USD | 6.87% |
2023 FY | 82.23 Million USD | 6.53% |
2023 Q3 | 76.94 Million USD | -0.74% |
2023 Q2 | 77.52 Million USD | -0.45% |
2022 Q2 | 64.66 Million USD | 11.62% |
2022 Q4 | 77.19 Million USD | 8.41% |
2022 Q3 | 71.2 Million USD | 10.12% |
2022 Q1 | 57.92 Million USD | -8.57% |
2022 FY | 77.19 Million USD | 21.84% |
2021 FY | 63.36 Million USD | 11.37% |
2021 Q1 | 61.38 Million USD | 7.9% |
2021 Q2 | 62.6 Million USD | 1.98% |
2021 Q3 | 68.37 Million USD | 9.22% |
2021 Q4 | 63.36 Million USD | -7.33% |
2020 Q1 | 86.85 Million USD | -67.86% |
2020 FY | 56.89 Million USD | -78.95% |
2020 Q2 | 60.13 Million USD | -30.76% |
2020 Q4 | 56.89 Million USD | 6.51% |
2020 Q3 | 53.41 Million USD | -11.17% |
2019 Q1 | - USD | 0.0% |
2019 Q4 | 270.23 Million USD | 0.0% |
2019 FY | 270.23 Million USD | 20.2% |
2018 FY | 224.81 Million USD | 0.0% |
Name | Total Liabilities | Total Liabilities Difference |
---|---|---|
Accuray Incorporated | 423.54 Million USD | 71.754% |
Align Technology, Inc. | 2.45 Billion USD | 95.124% |
Elevance Health Inc. | 69.52 Billion USD | 99.828% |
AxoGen, Inc. | 101.16 Million USD | -18.262% |
Boston Scientific Corporation | 15.6 Billion USD | 99.233% |
CVS Health Corporation | 173.09 Billion USD | 99.931% |
Cardinal Health, Inc. | 48.33 Billion USD | 99.752% |
Centene Corporation | 58.68 Billion USD | 99.796% |
DaVita Inc. | 14.87 Billion USD | 99.196% |
HCA Healthcare, Inc. | 55.15 Billion USD | 99.783% |
Hologic, Inc. | 4.02 Billion USD | 97.028% |
Humana Inc. | 30.74 Billion USD | 99.611% |
IDEXX Laboratories, Inc. | 1.77 Billion USD | 93.261% |
Laboratory Corporation of America Holdings | 8.83 Billion USD | 98.646% |
Masimo Corporation | 1.67 Billion USD | 92.865% |
McKesson Corporation | 69.04 Billion USD | 99.827% |
Patterson Companies, Inc. | 1.89 Billion USD | 93.687% |
Quest Diagnostics Incorporated | 7.6 Billion USD | 98.427% |
ResMed Inc. | 2 Billion USD | 94.043% |
Henry Schein, Inc. | 5.42 Billion USD | 97.793% |
Teladoc Health, Inc. | 2.06 Billion USD | 94.21% |
Universal Health Services, Inc. | 8.15 Billion USD | 98.533% |
Veeva Systems Inc. | 1.26 Billion USD | 90.551% |
Baxter International Inc. | 19.8 Billion USD | 99.396% |
Becton, Dickinson and Company | 26.98 Billion USD | 99.557% |
Intuitive Surgical, Inc. | 2.04 Billion USD | 94.148% |
Danaher Corporation | 30.99 Billion USD | 99.614% |
Stryker Corporation | 21.31 Billion USD | 99.439% |
Medtronic plc | 39.56 Billion USD | 99.698% |